IRLAB Therapeutics AB
556931-4692ActiveDeveloping novel CNS drugs for Parkinson's disease using proprietary technology.
Biotechnology Companyirlab.se
Oversigt
- 1–4
- Medarbejdere
- 5–10mio SEK
- Omsætning
- 2013
- Grundlagt
Nøglebeslutningstagere
Kristina Torfgård
Chief Executive Officer (CEO)
@irlab.se+46730XXXXXX
Clas Sonesson
Chief Scientific Officer (CSO)
@irlab.se
Carola Lemne
Chair of the Board
@irlab.se
Nicholas Waters
Executive Vice President and Head of R&D
@irlab.se
+4 flere kontakter i Funnelfeedr
Beskrivelse
IRLAB Therapeutics AB is a rapidly growing, publicly traded biotechnology company rooted in Nobel Prize-winning research. The organization specializes in discovering and developing novel treatments for Parkinson’s disease (PD) and other Central Nervous System (CNS) disorders. IRLAB utilizes its prop...